Psychedelic Experiences After Bereavement Improve Symptoms of Grief: The Influence of Emotional Breakthroughs and Challenging Experiences
Journal of Psychoactive Drugs June 21, 2023 DOI: 10.1080/02791072.2023.2228303 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Survey Qualitative Peer reviewed |
|---|---|
| Sample size | 363 |
| Population | Recreational psychedelic users who had suffered a bereavement event |
| Keywords | Traumatic grief Psychotherapist Disenfranchised grief Clinical psychology |
| Citations | 15 |
| Key findings | Improvements in grief symptoms after a psychedelic experience were reported, with a large effect size, and emotional breakthroughs were positively associated with symptom improvement. |
Abstract
Grief, a common reaction to loss, can frequently become problematic or impairing. Available treatments for prolonged grief disorder are promising but leave room for considerable improvement. Qualitative accounts of psychedelic experiences after bereavement reveal themes that parallel core components of prolonged grief disorder therapy. However, few studies have investigated the therapeutic potential of psychedelics for symptoms of grief. The present study surveyed recreational psychedelic users (N = 363) who had suffered a bereavement event. They reported retrospective grief symptoms before and after the psychedelic experience as well as subjective reactions to the psychedelic, including emotional breakthroughs and challenging experiences. Results indicate improvements in grief symptoms after a psychedelic experience, with a large effect size (Cohen’s d = 0.83). The occurrence of emotional breakthroughs was positively associated with improvements in symptoms of grief, while the converse relation was observed for challenging experiences. Findings provide preliminary evidence that support the development of a psychedelic-assisted therapy protocol to target symptoms of grief. Psychedelic-assisted therapy might offer an alternative to current grief treatment options.
Citations in the library
Cited by 13
- ‘Mind-Revealing’ Psychedelic States: Psychological Processes in Subjective Experiences That Drive Positive Change Psychoactives September 27, 2024
- Psychedelics and autobiographical memory - six open questions. Psychopharmacology March 17, 2025
- Narrative review of the potential for psychedelics to treat Prolonged Grief Disorder International Review of Psychiatry May 23, 2024
- Down the Rabbit Hole: A Large-Scale Survey of Psychedelic Users’ Patterns of Use and Perceived Effects Journal of Psychoactive Drugs January 29, 2025
- Psilocybin with psychotherapeutic support for treatment-resistant depression: a pilot clinical trial Therapeutic Advances in Psychopharmacology September 1, 2025
and 8 more in the library
Cites 18
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder JAMA Psychiatry November 4, 2020
- Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial Psychological Medicine June 15, 2018
- Psychedelics and the essential importance of context. Journal of Psychopharmacology February 15, 2018
and 13 more in the library